Abbott & Medtronic Team Up - Omnipod 5's iPhone App

This newsletter will keep you up to date on the latest in diabetes tech and research, along with updates on our content releases.

Today I’ll get into Abbott and Medtronic’s Groundbreaking CGM partnership, my experience using the Omnipod 5 iPhone app, and early screening of T1D.

Omnipod 5 + the iPhone App - So Far

I've been using Omnipod 5 for just over three weeks, and I'm happy to report it’s been a positive experience. I made the switch after I was invited to try the iPhone app during its Limited Market Release. This was the perfect opportunity to see first-hand how the system and app work.

To see how my first week went, check out this video:

I love it the Omnipod 5 iPhone app - it’s a complete redesign from the Android and PDM app and is clean and intuitive. No word on release date yet…but Insulet says it will release this year. For my thoughts on the app so far, what this video:

Omnipod 5 marks the start of my journey to try out as many pumps as possible, so I can become even more knowledgeable and provide you with better insights into the tech and its potential.

The BIGGEST news this week

Abbott and Medtronic just announced a global partnership to integrate Libre CGMs into Medtronic insulin systems. The CGMs will be manufactured by Abbott and sold by Medtronic as proprietary sensors, designed to work exclusively with Medtronic pumps.

In other news, Medtronic received FDA clearance for its Simplera CGM, but that announcement got a bit overshadowed. It makes me wonder if there might be some dissatisfaction with Simplera’s performance…

I’ll be releasing a video next Friday on YouTube, where I break down the deal and what it could mean for the future of all-in-one pump + CGM device. For now, you can check out Medtronic’s press release and watch my coverage on TikTok:

@diabe_tech

New CGM coming for Medtronic pumps, built with Libre tech. This is huge! #cgm #t1d #diabetes

In case you missed it on diabetech…

On the latest podcast, I spoke with CeQur Simplicity’s CEO about its insulin patch. The device sits somewhere between a tubeless pump and insulin injections and is used alongside long acting insulin.

The small patch holds 200 units of insulin and is adhered to the body using an applicator. Users pinch the top and bottom of the device to inject increments of 2 units of bolus insulin as many times as needed.

To hear more about how it works, listen to the episode or watch it here:

Legislation for early screening of T1D

My latest piece on CNET dives into my type 2 misdiagnosis and how others can get screened for t1d. I cover a bipartisan bill introduced in the US that could allocate funds to increase awareness and screening for t1d. Read it here:

Thanks for your support!